| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 12/17/2009 | US20090311196 Pharmaceutical aerosol composition |
| 12/17/2009 | US20090311190 Self-assembled, micropatterned, and radio frequency (rf) shielded biocontainers and their uses for remote spatially controlled chemical delivery |
| 12/17/2009 | US20090311184 High penetration prodrug compositions of peptides and peptide-related compounds |
| 12/17/2009 | US20090311179 Selective Targeting of Apoptotic Cells |
| 12/17/2009 | US20090308407 Device adapted to release a hair substance |
| 12/17/2009 | CA2731138A1 Compositions for treating rosacea |
| 12/17/2009 | CA2727813A1 Crystalline polymorphs of gemcitabine base |
| 12/17/2009 | CA2727630A1 Pharmaceutical formulations |
| 12/17/2009 | CA2727488A1 Tablet quickly disintegrating in the oral cavity and method for producing the same |
| 12/17/2009 | CA2727447A1 Fluid bed meal containing a marker and methods of making |
| 12/17/2009 | CA2727417A1 Liposomes capable of effectively binding the beta amyloid peptide |
| 12/17/2009 | CA2727309A1 Novel embedment particles for inhalation |
| 12/17/2009 | CA2727297A1 New emulsions for producing medicinal products |
| 12/17/2009 | CA2727206A1 Process for making gastroretentive dosage forms |
| 12/17/2009 | CA2727094A1 Unit dose formulations of ketorolac for intranasal administration |
| 12/17/2009 | CA2727019A1 Rasagiline soft gelatin capsules |
| 12/17/2009 | CA2726700A1 Modified protein excipient for delayed-release tablet |
| 12/17/2009 | CA2726616A1 Pharmaceutical compositions containing a fluoroquinolone antibiotic drug |
| 12/17/2009 | CA2726502A1 In situ gelling systems as sustained delivery for front of eye |
| 12/17/2009 | CA2725530A1 Nanoparticles containing a peptide, vectors containing the same and pharmaceutical uses of said nanoparticles and said vectors |
| 12/17/2009 | CA2725482A1 Controlled release formulations of pramipexole |
| 12/17/2009 | CA2724992A1 Magnesium system and use thereof in the cosmetics industry |
| 12/17/2009 | CA2724903A1 Use of a matrix for orally administering sustained release magnesium, and composition containing said matrix |
| 12/17/2009 | CA2724244A1 Pharmaceutical formulations comprising stabilized polysaccharides and source of hydrogen peroxide |
| 12/17/2009 | CA2723824A1 Biocompatible and biodegradable elastomeric polymers |
| 12/16/2009 | EP2133725A2 Apparatus for nanofabrication using multi-photon excitation |
| 12/16/2009 | EP2133325A1 Derivatives of venlafaxine and methods of preparing and using the same |
| 12/16/2009 | EP2133098A1 G-CSF conjugates |
| 12/16/2009 | EP2133097A1 Transpulmonary liposome for controlling drug arrival |
| 12/16/2009 | EP2133096A2 Oral disintegrating tablet |
| 12/16/2009 | EP2133092A1 Oral vaccine |
| 12/16/2009 | EP2133084A2 Pharmaceutical Formulation Comprising Lanthanum Compounds |
| 12/16/2009 | EP2133073A1 Poly(lactide-co-glycolide)-based sustained release microcapsules comprising a polypeptide and a sugar |
| 12/16/2009 | EP2133072A1 Gastro-resistant pharmaceutical oral compositions comprising duloxetine or its pharmaceutically acceptable derivatives |
| 12/16/2009 | EP2133071A1 Process for making gastroretentive dosage forms |
| 12/16/2009 | EP2133070A1 Pharmaceutical compositions comprising a HMG COA reductase inhibitor |
| 12/16/2009 | EP2133069A1 Process for manufacture of gelatin solutions and products thereof |
| 12/16/2009 | EP2133068A1 Method for selecting a suitable excipient for producing solid dispersions for pharmaceutical formulas |
| 12/16/2009 | EP2133060A1 Process for producing preparation for oral administration |
| 12/16/2009 | EP2132173A1 Formulations for cathepsin k inhibitors |
| 12/16/2009 | EP2131830A2 Pharmaceutical form with impeded abuse |
| 12/16/2009 | EP2131824A1 Fast-dissolving/disintegrating film preparation having high proportion of active |
| 12/16/2009 | EP2131823A2 Rapid-disintegration monolayer film for the oral administration of active substances |
| 12/16/2009 | EP2131822A1 Divalent metal-ion loaded nano-transport system having a dendritic architecture useful for therapy |
| 12/16/2009 | EP2131821A1 Nanoparticle comprising rapamycin and albumin as anticancer agent |
| 12/16/2009 | EP2131820A1 Sulfone polymer compositions |
| 12/16/2009 | EP2131818A2 Novel dosage form |
| 12/16/2009 | EP2131817A2 Pharmaceutical composition of quetiapine fumarate |
| 12/16/2009 | EP2131816A1 Pharmaceutical analysis apparatus and method |
| 12/16/2009 | EP2131815A1 Coacervation process |
| 12/16/2009 | EP2131814A2 Polymeric micelles for combination drug delivery |
| 12/16/2009 | EP2131813A2 Topical pharmaceutical formulation |
| 12/16/2009 | EP2131812A2 Gaseous mixture containing o2 and n2o for preventing or reducing hyperalgesia |
| 12/16/2009 | EP2131811A2 Palatable product |
| 12/16/2009 | EP2131810A2 Oral administration of a calcitonin |
| 12/16/2009 | EP2131809A2 Methods and compositions for normalizing meibomian gland secretions |
| 12/16/2009 | EP2131808A1 Implant containing destructurized starch |
| 12/16/2009 | EP2131674A2 Allergen-free, protein-free or at least dairy free powdered nutritional compositions and the use thereof in food products |
| 12/16/2009 | EP1941062B1 Method for producing a saccharose composition, resulting product and use thereof |
| 12/16/2009 | EP1592407B1 Sustained release device and method for ocular delivery of carbonic anhydrase inhibitors |
| 12/16/2009 | EP1327442B1 Process for producing gel sheet for application to living body, gel sheet for application to living body obtained by the production process, and method of skin care with the same |
| 12/16/2009 | EP0824541B1 Nucleic acid ligand complexes |
| 12/16/2009 | CN201361268Y Cordyceps vigorine tablet |
| 12/16/2009 | CN101605892A Rna interference mediated inhibition of map kinase genes |
| 12/16/2009 | CN101605548A Liposome encapsulated poly-ICLC method to prophylactically treat an avian influenza viral infection |
| 12/16/2009 | CN101605546A Method for prevention of discoloration with time of donepezil-containing skin adhesive preparation |
| 12/16/2009 | CN101605545A Skin adhesive preparation comprising stabilized donepezil |
| 12/16/2009 | CN101605537A Benzoyl peroxyde comprising compositions, at least one naphtoic acid derivative and at least one compound of polyurethane polymer-type or derivatives thereof, and their use |
| 12/16/2009 | CN101605536A Microdevice and method for transdermal delivery and sampling of active substances |
| 12/16/2009 | CN101605535A Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane |
| 12/16/2009 | CN101605534A A spinal nucleus pulposus implant |
| 12/16/2009 | CN101605533A Process for preparation of a stable dispersion of solid amorphous submicron particles in an aqueous medium |
| 12/16/2009 | CN101605532A Protein formulations containing sorbitol |
| 12/16/2009 | CN101605531A Ophthalmic compositions containing a synergistic combination of three polymers |
| 12/16/2009 | CN101605530A Pharmaceutical formulations and methods for making the same |
| 12/16/2009 | CN101605529A Stable formulations, and methods of their preparation and use |
| 12/16/2009 | CN101605468A Improved stability in vitamin and mineral supplements |
| 12/16/2009 | CN101605466A Free-flowing gelatin composition |
| 12/16/2009 | CN101602793A Immunoregulatory polypeptide for preventing and/or treating rheumatoid arthritis and application thereof |
| 12/16/2009 | CN101602791A Integrin receptor target lipidosome drug carrier, preparation method and application thereof |
| 12/16/2009 | CN101601855A Analysis method of Guilong kechuangning tablet |
| 12/16/2009 | CN101601852A Chinese medicine preparation for treating vascular migraine |
| 12/16/2009 | CN101601851A External application patch for treating scapulohumeral periarthritis and preparation technology thereof |
| 12/16/2009 | CN101601850A Lactagogue and health care traditional Chinese medicine for lying-in women |
| 12/16/2009 | CN101601849A Manufacturing method of hyperosteogeny liniment |
| 12/16/2009 | CN101601848A Preparation method of plaster for curing wind cold dampness |
| 12/16/2009 | CN101601845A Preparation method of pills for eliminating cardialgia |
| 12/16/2009 | CN101601844A Preparation method of ointment for clearing infantile tetanus neonatorium |
| 12/16/2009 | CN101601843A Medicament for treating prostatitis |
| 12/16/2009 | CN101601842A Health care product for relieving and preventing ocular diseases and preparation method thereof |
| 12/16/2009 | CN101601840A Medicament for treating hepatolenticular degeneration |
| 12/16/2009 | CN101601839A Manufacturing method of external solution for rheumatoid arthritis |
| 12/16/2009 | CN101601838A Manufacturing method of external solution for enabling lumbar disc herniation to recover |
| 12/16/2009 | CN101601837A Manufacturing method external analgesic solution for neck and shoulder diseases |
| 12/16/2009 | CN101601836A Preparation method of Hongmao wine for removing stomach ache |
| 12/16/2009 | CN101601835A Tumor post-operation treating medicine and preparation method thereof |
| 12/16/2009 | CN101601833A Preparation method of powder for clearing gastric ulcer |
| 12/16/2009 | CN101601832A Drug for treating chronic pelvic inflammation and preparing method thereof |
| 12/16/2009 | CN101601831A Medicament for treating neurodermatitis |
| 12/16/2009 | CN101601830A Chinese medicinal preparation for treating cold and preparation method thereof |